Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Active not recruiting 2

Sponsor Class

NIH 4OTHER 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 1Metastatic Castration-resistant Prostate Cancer 1

Interventions

Specimen Handling 123Magnetic Resonance Spectroscopy 117Cyclophosphamide 109pembrolizumab 88Radiotherapy 83Nivolumab 73Cisplatin 68fludarabine 65Biopsy 60Carboplatin 59Standard of Care 49Radiosurgery 45Gemcitabine 44Paclitaxel 42Dexamethasone 42Radiation 39Doxorubicin 39Rituximab 38Blood Specimen Collection 37Bevacizumab 37venetoclax 36Cytarabine 36Surveys and Questionnaires 35fludarabine phosphate 33Capecitabine 33Temozolomide 31Radiotherapy, Intensity-Modulated 31Practice Guidelines as Topic 31Ipilimumab 28Interviews as Topic 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × radium Ra 223 dichloride × 30 days × Clear all
NCT03344211 2026-06-03

Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer

University of Southern California

Phase 2 Active not recruiting
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT04109729 2026-06-01

Rad2Nivo

University of Utah

Phase 1 Active not recruiting
39 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡